Springfield, MO

Log in Subscribe

St. Louis biotech startup raises $105M in funding round

Posted online

St. Louis biotech startup Arch Oncology raised $105 million in a funding round.

The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.

Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.

Read more from the St. Louis Business Journal.


No comments on this story |
Please log in to add your comment
Editors' Pick
Business Spotlight: Steady Strides

Dynamic Strides Therapy to address growing demand with future expansion.

Most Read
Update cookies preferences